ImmunologybioRxivPreprint
Enhancing the iNKT cell immunotherapy platform by combining optimised CAR endodomains with novel iNKT engagers
Kanagaraju Ponnusamy, Klesti Karaxhuku, Yang Jiang…·Anastasios Karadimitris
This study enhances iNKT cell immunotherapy by combining optimized CAR endodomains with novel iNKT-specific engagers to improve anti-myeloma activity.
DOI 10.1101/2025.10.23.683869